120 related articles for article (PubMed ID: 35420246)
1. Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosis.
Engelmann C; Aehling NF; Schob S; Nonnenmacher I; Handmann L; Macnaughtan J; Herber A; Surov A; Kaiser T; Denecke T; Jalan R; Seehofer D; Moche M; Berg T
Hepatol Commun; 2022 Aug; 6(8):2198-2209. PubMed ID: 35420246
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI.
Cruz RJ; Dew MA; Myaskovsky L; Goodpaster B; Fox K; Fontes P; DiMartini A
Transplantation; 2013 Feb; 95(4):617-22. PubMed ID: 23348896
[TBL] [Abstract][Full Text] [Related]
4. Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and death.
Engelmann C; Schob S; Nonnenmacher I; Werlich L; Aehling N; Ullrich S; Kaiser T; Krohn S; Herber A; Sucher R; Bartels M; Surov A; Hasenclever D; Kahn T; Seehofer D; Moche M; Berg T
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1271-1281. PubMed ID: 30417398
[TBL] [Abstract][Full Text] [Related]
5. Computed Tomography Measures of Nutrition in Patients With End-Stage Liver Disease Provide a Novel Approach to Characterize Deficits.
Bush WJ; Davis JP; Maluccio MA; Kubal CA; Salisbury JB; Mangus RS
Transplant Proc; 2018 Dec; 50(10):3501-3507. PubMed ID: 30586837
[TBL] [Abstract][Full Text] [Related]
6. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
Montano-Loza AJ; Mazurak VC; Ebadi M; Meza-Junco J; Sawyer MB; Baracos VE; Kneteman N
Hepatology; 2018 Mar; 67(3):914-923. PubMed ID: 29023899
[TBL] [Abstract][Full Text] [Related]
7. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.
Ebadi M; Tandon P; Moctezuma-Velazquez C; Ghosh S; Baracos VE; Mazurak VC; Montano-Loza AJ
J Hepatol; 2018 Sep; 69(3):608-616. PubMed ID: 29709682
[TBL] [Abstract][Full Text] [Related]
8. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
Montano-Loza AJ; Meza-Junco J; Baracos VE; Prado CM; Ma M; Meeberg G; Beaumont C; Tandon P; Esfandiari N; Sawyer MB; Kneteman N
Liver Transpl; 2014 Jun; 20(6):640-8. PubMed ID: 24678005
[TBL] [Abstract][Full Text] [Related]
9. Visceral Adipose Tissue Index and Hepatocellular Carcinoma Are Independent Predictors of Outcome in Patients with Cirrhosis Having Endoscopic Treatment for Esophageal Varices.
Kimura N; Tsuchiya A; Oda C; Kimura A; Hosaka K; Tominaga K; Hayashi K; Yokoyama J; Terai S
Dig Dis; 2021; 39(1):58-65. PubMed ID: 32450556
[TBL] [Abstract][Full Text] [Related]
10. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy.
Ferrarese A; Battistella S; Germani G; Russo FP; Senzolo M; Gambato M; Vitale A; Cillo U; Burra P
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208613
[No Abstract] [Full Text] [Related]
11. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.
Kuo SZ; Ahmad M; Dunn MA; Montano-Loza AJ; Carey EJ; Lin S; Moghe A; Chen HW; Ebadi M; Lai JC
Transplantation; 2019 Nov; 103(11):2312-2317. PubMed ID: 30985575
[TBL] [Abstract][Full Text] [Related]
12. Impact of visceral fat accumulation on the prognosis of patients with cirrhosis.
Ishizu Y; Ishigami M; Honda T; Imai N; Ito T; Yamamoto K; Fujishiro M
Clin Nutr ESPEN; 2021 Apr; 42():354-360. PubMed ID: 33745605
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
14. Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease.
Goldberg D; French B; Newcomb C; Liu Q; Sahota G; Wallace AE; Forde KA; Lewis JD; Halpern SD
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1638-1646.e2. PubMed ID: 27374003
[TBL] [Abstract][Full Text] [Related]
15. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis.
Ebadi M; Bhanji RA; Tandon P; Mazurak V; Baracos VE; Montano-Loza AJ
Aliment Pharmacol Ther; 2020 Aug; 52(4):600-618. PubMed ID: 32621329
[TBL] [Abstract][Full Text] [Related]
16. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation.
Wedd J; Bambha KM; Stotts M; Laskey H; Colmenero J; Gralla J; Biggins SW
Liver Transpl; 2014 Oct; 20(10):1193-201. PubMed ID: 24916539
[TBL] [Abstract][Full Text] [Related]
17. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
18. A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation.
Leung DH; Narang A; Minard CG; Hiremath G; Goss JA; Shepherd R
Liver Transpl; 2016 Nov; 22(11):1584-1592. PubMed ID: 27541809
[TBL] [Abstract][Full Text] [Related]
19. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
20. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
